Some scientific research about (2S,3S,4S,5R,6R)-2-(Methoxycarbonyl)-6-(2,2,2-trichloro-1-iminoethoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 92420-89-8, help many people in the next few years., Application of 92420-89-8

Application of 92420-89-8, An article , which mentions 92420-89-8, molecular formula is C15H18Cl3NO10. The compound – (2S,3S,4S,5R,6R)-2-(Methoxycarbonyl)-6-(2,2,2-trichloro-1-iminoethoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate played an important role in people’s production and life.

Development of a stereoselective practical synthetic route to indolmycin, a candidate anti-H. pylori agent

A stereoselective practical synthetic route to indolmycin is described. The route is composed of the regioselective coupling of indolyl magnesium halide with a trans-epoxy ester, diastereoselective oxazolone ring formation with guanidine and amine exchange reaction with methylamine. In the coupling step, use of dichloromethane as co-solvent and conversion of the resulting hydroxy ester to the hydroxy acid for purification, make this process efficient and practical. The oxazolone ring is formed in good yield without epimerization at the C5 position by treatment with guanidine and potassium tert-butoxide in tert-butanol at room temperature. In the final step, the amino group is efficiently converted to the methylamino group in aqueous methylamine solution at 5 C. After examination of the route with racemates, indolmycin was synthesized stereoselectively in 22% total yield from optically active trans-epoxy ester. This route was applied to the preparation of the metabolites of indolmycin.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 92420-89-8, help many people in the next few years., Application of 92420-89-8

Reference:
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics